1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Finland >
  5. Curium Pharma Acquires MAP Medical Technologies Oy

M&A Deal Summary

Curium Pharma Acquires MAP Medical Technologies Oy

On December 2, 2019, Curium Pharma acquired life science company MAP Medical Technologies Oy

Acquisition Highlights
  • This is Curium Pharma’s 1st transaction in the Life Science sector.
  • This is Curium Pharma’s 1st transaction in Finland.

M&A Deal Summary
Date 2019-12-02
Target MAP Medical Technologies Oy
Sector Life Science
Buyer(s) Curium Pharma
Deal Type Add-on Acquisition

Target

MAP Medical Technologies Oy

Tikkakoski, Finland
MAP Medical Technologies Oy is focused on developing and manufacturing radiopharmaceuticals. MAP Medical Technologies is based in Tikkakoski, Finland.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Curium Pharma

Paris, France
Category Company
Founded 2017
Sector Life Science
DESCRIPTION

Curium Pharma is the largest nuclear medicine company with more than a century of industry experience. Curium develops, manufacture, and distribute world-class radiopharmaceutical products to help patients around the globe. Curium Pharma was founded in 2017 and is based in Paris, France.

DEAL STATS #
Overall 1 of 3
Sector: Life Science M&A 1 of 3
Type: Add-on Acquisition M&A Deals 1 of 3
Country: Finland M&A 1 of 1
Year: 2019 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-08 Eczacıbaşı-Monrol

Istanbul, Turkey

Eczacıbaşı-Monrol is an innovative, international supplier of radiopharmaceuticals for diagnosis and treatment in nuclear medicine. Eczacıbaşı-Monrol is based in Istanbul, Turkey.

Buy -
Mergr

Solution for

Product

Company

Legal